Centre de Référence
des Maladies Autoinflammatoires
et des Amyloses

 
 
 
 
 
 

Publications

In press

A comparative clinical trial to assess a standardized escalation dose strategy of interleukin-1 blockade in Kawasaki disease: The ANACOMP trial
Koné-Paut I, Toumazi A, Bourmaud A
CLIN INVESTIG (LOND) - 2021

Mevalonate kinase-associated diseases: hunting for phenotype–genotype correlation
Guilaine Boursier, Cécile Rittore, Florian Milhavet, Laurence Cuisset, Isabelle Touitou
J CLIN MED - 2021

 

2021 Voir une autre année ?

Regulatory T cell/Th17 balance in the pathogenesis of pediatric Behçet disease.
Filleron A, Tran TA, Hubert A, Letierce A, Churlaud G, Koné-Paut I, Saadoun D, Cezar R, Corbeau P, Rosenzwajg M.
Rheumatology (Oxford), 2021 Mar 18. pii: keab253. doi: 10.1093/rheumatology/keab253. Epub 2021 Mar 18.

LACC1 deficiency links juvenile arthritis with autophagy and metabolism in macrophages.
Omarjee O, Mathieu AL, Quiniou G, Moreews M, Ainouze M, Frachette C, Melki I, Dumaine C, Gerfaud-Valentin M, Duquesne A, Kallinich T, Tahir Turanli E, Malcus C, Viel S, Pescarmona R, Georgin-Lavialle S, Jamilloux Y, Larbre JP, Sarrabay G, Magnotti F, Rice GI, Bleicher F, Reboulet J, Merabet S, Henry T, Crow YJ, Faure M, Walzer T, Belot A.
J Exp Med, 2021 Mar 1. pii: e20201006. doi: 10.1084/jem.20201006.

TNFR1-d2 carrying the p.(Thr79Met) pathogenic variant is a potential novel actor of TNFα/TNFR1 signalling regulation in the pathophysiology of TRAPS.
Rittore C, Méchin D, Sanchez E, Marinèche L, Ea V, Soler S, Vereecke M, Mallavialle A, Richard E, Duroux-Richard I, Apparailly F, Touitou I, Grandemange S.
Sci Rep, 2021 Feb 18. 11(1):4172. doi: 10.1038/s41598-021-83539-9. Epub 2021 Feb 18.

French recommendations for the management of Behçet's disease.
Kone-Paut I, Barete S, Bodaghi B, Deiva K, Desbois AC, Galeotti C, Gaudric J, Kaplanski G, Mahr A, Noel N, Piram M, Tran TA, Wechsler B, Saadoun D, Collaborators..
Orphanet J Rare Dis, 2021 Feb 24. 16(Suppl 1):352. doi: 10.1186/s13023-020-01620-4. Epub 2021 Feb 24.

EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19.
Alunno A, Najm A, Machado PM, Bertheussen H, Burmester GR, Carubbi F, De Marco G, Giacomelli R, Hermine O, Isaacs JD, Koné-Paut I, Magro-Checa C, McInnes I, Meroni PL, Quartuccio L, Ramanan AV, Ramos-Casals M, Rodríguez Carrio J, Schulze-Koops H, Stamm TA, Tas SW, Terrier B, McGonagle DG, Mariette X.
Ann Rheum Dis, 2021 Feb 5. pii: annrheumdis-2020-219724. doi: 10.1136/annrheumdis-2020-219724. Epub 2021 Feb 5.

Therapeutic alliance is associated to treatment adherence in children with juvenile idiopathic arthritis.
Lohse A, Lemelle I, Pillet P, Duquesne A, Ballot C, Tran TA, Sparsa L, Goumy L, Reumaux H, Rossi L, Solau-Gervais E, Arbault A, Alleyrat C, Guillemin F, Devauchelle-Pensec V.
Joint Bone Spine, 2021 Feb 6. 88(4):105151. doi: 10.1016/j.jbspin.2021.105151. Epub 2021 Feb 6.

Delineating phenotypes of Kawasaki disease and SARS-CoV-2-related inflammatory multisystem syndrome: A French study and literature review.
Cherqaoui B, Koné-Paut I, Yager H, Bourgeois FL, Piram M.
Rheumatology (Oxford), 2021 Jan 25. pii: keab026. doi: 10.1093/rheumatology/keab026. Epub 2021 Jan 25.